MedTrace Logo

Registry Protocol for Tracking Trial Subjects After VTI-206 Study Completion

NCT01452295 · Status: WITHDRAWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL

Last updated 2013-12-04

No results posted yet for this study

Summary

VTI-207 (NCT01452295) is designed to follow subjects, both treated and control, for five years after their completion of study participation in protocol VTI-206 (NCT00973817) to gather information relating to the incidence of liver transplant, the incidence and type of cancer (if any), and survival.

Conditions

  • Acute Liver Failure

Interventions

DRUG

ELAD (Extracorporeal Liver Assist System)

ELAD (Extracorporeal Liver Assist System)

Sponsors & Collaborators

  • Vital Therapies, Inc.

    lead INDUSTRY

Principal Investigators

  • Robert A Ashley · Vital Therapies, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2012-09-30
Completion
2012-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01452295 on ClinicalTrials.gov